Among the assigned pathways significantly downregulated in NASH-HCC compared with NASH patients were necroptosis, amino acid metabolism, and regulation of lipid metabolism by PPAR-α, biogenic amine synthesis, fatty acid metabolism, and mTOR signaling pathway. Here, MTOR is linked to metabolic dysfunction-associated steatohepatitis.